» Articles » PMID: 25905889

Rare, Serious, and Comprehensively Described Suspected Adverse Drug Reactions Reported by Surveyed Healthcare Professionals in Uganda

Overview
Journal PLoS One
Date 2015 Apr 24
PMID 25905889
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lack of adequate detail compromises analysis of reported suspected adverse drug reactions (ADRs). We investigated how comprehensively Ugandan healthcare professionals (HCPs) described their most recent previous-month suspected ADR, and determined the characteristics of HCPs who provided comprehensive ADR descriptions. We also identified rare, serious, and unanticipated suspected ADR descriptions with medication safety-alerting potential.

Methods: During 2012/13, this survey was conducted in purposively selected Ugandan health facilities (public/private) including the national referral and six regional referral hospitals representative of all regions. District hospitals, health centres II to IV, and private health facilities in the catchment areas of the regional referral hospitals were conveniently selected. Healthcare professionals involved in prescribing, transcribing, dispensing, and administration of medications were approached and invited to self-complete a questionnaire on ADR reporting. Two-thirds of issued questionnaires (1,345/2,000) were returned.

Results: Ninety per cent (241/268) of HCPs who suspected ADRs in the previous month provided information on five higher-level descriptors as follows: body site (206), drug class (203), route of administration (127), patient age (133), and ADR severity (128). Comprehensiveness (explicit provision of at least four higher-level descriptors) was achieved by at least two-fifths (46%, 124/268) of HCPs. Received descriptions were more likely to be comprehensive from HCPs in private health facilities, regions other than central, and those not involved in teaching medical students. Overall, 106 serious and 51 rare previous-month suspected ADRs were described. The commonest serious and rare ADR was Stevens-Johnson syndrome (SJS); mostly associated with oral nevirapine or cotrimoxazole, but haemoptysis after diclofenac analgesia and paralysis after quinine injection were also described.

Conclusion: Surveyed Ugandan HCPs who had suspected at least one ADR in the previous month competently provided comprehensive ADR descriptions: more, indeed, than are received per annum nationally. Properly analyzed, and with local feed-back, voluntary ADR reports by HCPs could be an essential alerting tool for identifying rare and serious suspected ADRs in Uganda.

Citing Articles

Adverse Drug Reaction Onsets in Uganda's VigiBase: Delayed International Visibility, Data Quality and Illustrative Signal Detection Analyses.

Kiguba R, Ndagije H, Nambasa V, Bird S Pharmaceut Med. 2018; 32(6):413-427.

PMID: 30546260 PMC: 6267548. DOI: 10.1007/s40290-018-0253-7.


Antibiotic-associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study.

Kiguba R, Karamagi C, Bird S Pharmacol Res Perspect. 2017; 5(2):e00298.

PMID: 28357124 PMC: 5368962. DOI: 10.1002/prp2.298.


Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients.

Kiguba R, Karamagi C, Bird S BMJ Open. 2017; 7(1):e010568.

PMID: 28110281 PMC: 5253535. DOI: 10.1136/bmjopen-2015-010568.


Medication Error Disclosure and Attitudes to Reporting by Healthcare Professionals in a Sub-Saharan African Setting: A Survey in Uganda.

Kiguba R, Waako P, Ndagije H, Karamagi C Drugs Real World Outcomes. 2015; 2(3):273-287.

PMID: 26594614 PMC: 4650198. DOI: 10.1007/s40801-015-0032-7.

References
1.
Van Renterghem D, Depuydt C . Hemoptysis and pulmonary edema in a scuba diver using diclofenac. Pharmacology. 2012; 89(1-2):103-4. DOI: 10.1159/000336059. View

2.
Barvaliya M, Sanmukhani J, Patel T, Paliwal N, Shah H, Tripathi C . Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study. J Postgrad Med. 2011; 57(2):115-9. DOI: 10.4103/0022-3859.81865. View

3.
Etminan M, Gill S, Fitzgerald M, Samii A . Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making. J Clin Pharmacol. 2006; 46(1):6-9. DOI: 10.1177/0091270005283285. View

4.
Tumwikirize W, Ogwal-Okeng J, Vernby A, Anokbonggo W, Gustafsson L, Lundborg S . Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda. Afr Health Sci. 2011; 11(1):72-8. PMC: 3092317. View

5.
Yiannakopoulou E . Hemoptysis under diclofenac and antiplatelet doses of aspirin. Pharmacology. 2010; 87(1-2):1-4. DOI: 10.1159/000321728. View